BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35818332)

  • 1. Dexmedetomidine Inhibits NF-κB-Transcriptional Activity in Neurons Undergoing Ischemia-Reperfusion by Regulating O-GlcNAcylation of SNW1.
    She C; Zhu J; Liu A; Xu Y; Jiang Z; Peng Y
    J Neuropathol Exp Neurol; 2022 Sep; 81(10):836-849. PubMed ID: 35818332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
    Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
    Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
    J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury by Suppressing TLR4-MyD88-NF-
    Gao JM; Meng XW; Zhang J; Chen WR; Xia F; Peng K; Ji FH
    Biomed Res Int; 2017; 2017():1674613. PubMed ID: 29359143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine attenuates oxygen-glucose deprivation/ reperfusion-induced inflammation through the miR-17-5p/ TLR4/ NF-κB axis.
    Suo L; Wang M
    BMC Anesthesiol; 2022 Apr; 22(1):126. PubMed ID: 35488217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
    Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
    Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
    Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
    Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis.
    Liu W; Shao C; Zang C; Sun J; Xu M; Wang Y
    BMC Anesthesiol; 2021 Aug; 21(1):203. PubMed ID: 34399695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
    Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
    J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway.
    Dong X; Shu L; Zhang J; Yang X; Cheng X; Zhao X; Qu W; Zhu Q; Shou Y; Peng G; Sun B; Yi W; Shu Q; Li X
    J Neuroinflammation; 2023 Jun; 20(1):146. PubMed ID: 37349834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway.
    Zhang B; Zhang J; Ainiwaer Y; He B; Geng Q; Lin L; Li X
    Ann Clin Lab Sci; 2021 May; 51(3):376-384. PubMed ID: 34162568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
    Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
    Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression.
    Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS
    Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
    Bao N; Tang B; Wang J
    J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preactivation of Notch1 in remote ischemic preconditioning reduces cerebral ischemia-reperfusion injury through crosstalk with the NF-κB pathway.
    Liang W; Lin C; Yuan L; Chen L; Guo P; Li P; Wang W; Zhang X
    J Neuroinflammation; 2019 Sep; 16(1):181. PubMed ID: 31526384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNW1, a Novel Transcriptional Regulator of the NF-κB Pathway.
    Verma S; De Jesus P; Chanda SK; Verma IM
    Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30397075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis.
    Liu Q; Wu J; Lai S; Li G
    Neurochem Res; 2022 Jul; 47(7):2064-2075. PubMed ID: 35538293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion.
    Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM
    Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.